SCHEMBL25508995

SCHEMBL25508995

c1ccc2cc(-c3nc(-c4cccc5c4ccc4c6ccccc6ccc54)nc(-c4cncc5oc6ccccc6c45)n3)ccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.36
CYP11B2 P19099 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2B6 P20813 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
KDM4E B2RXH2 4/20 0.34
PIM1 P11309 1/20 0.33
PRKCZ Q05513 1/20 0.33
ALDH1A1 P00352 4/20 0.33
MAPT P10636 4/20 0.33
ERN1 O75460 1/20 0.33
MEN1 O00255 1/20 0.32
ESR1 P03372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25509112 0.95 CYP11B1 (0.38) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6
SCHEMBL25509115 0.95 CYP1A2 (0.37) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6
SCHEMBL25509114 0.94 CYP11B1 (0.37) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6
SCHEMBL25509103 0.94 CYP11B1 (0.38) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6
SCHEMBL25509206 0.94 TDP1 (0.37) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6
SCHEMBL25508992 0.93 CYP11B1 (0.36) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6
SCHEMBL23947026 0.92 CYP11B1 (0.37) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6
SCHEMBL25508886 0.92 CYP11B1 (0.38) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6
SCHEMBL25509215 0.92 CYP11B1 (0.38) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6
SCHEMBL23946598 0.92 CYP11B1 (0.41) CYP11B1CYP11B2CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240237518-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-07-11 US disclosed
US-20240237518-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-07-11 US disclosed
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-06-27 US disclosed
US-20230174544-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-06-08 US disclosed
US-20230174544-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-06-08 US disclosed
WO-2023090836-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-05-25 WO disclosed
WO-2023085878-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-05-19 WO disclosed
WO-2023085908-A1 ORGANIC LIGHT EMITTING DEVICE 주식회사 엘지화학 2023-05-19 WO disclosed
WO-2023085881-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174544-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY2, CYBA, AHR CYP11B1 1001/4885CYP11B2 1023/4885CYP1A2 202/4885
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE CRY2, CRY1, AHR CYP11B1 358/4885CYP11B2 359/4885CYP1A2 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.